Alphabet’s “moonshot” subsidiary X shared that it failed to find a single biomarker for depression and anxiety. But the company still plans to make its research, which included developing portable EEGs, available to the public.
The Administration for Community Living, part of the Department of Health and Human Services, is taking steps to establish a National Volunteer Care Corps.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Salt Lake City-based Myriad Genetics' GeneSight screening analyzes specific genes as a way to predict the effectiveness of 56 common medications for depression.
The company's cell phone-sized device delivers low-level electric stimulation to the trigeminal nerve through a patch placed on a patient's forehead.
Based on the literature review conducted by the researchers, only 14 percent of top ranked behavioral health apps described design or development that was based on real-world evidence.
An analyst said the news could negatively affect shares of a successor to the company that developed rapastinel - which Allergan bought in 2015 - given that its drugs belong to the same class.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
The drug, a reformulation of ketamine, was approved for patients who have failed on other antidepressants. The original form of ketamine, approved as an anesthetic, has long been explored as a treatment for depression.
The company's shares were down more than 4 percent in Monday morning trading after the agency's decision, which itself followed a negative AdCom vote in November.
Panelists at the MedCity Engage conference in San Diego agreed that a growing shortage of mental health professionals mean that technology has a key role to play in improving behavioral health treatment.
The San Francisco-based startup's platform aids care coordinators to assess and identify both clinical and sociodemographic risk factors for chronic illnesses like diabetes, COPD, chronic kidney disease, depression and congestive heart failure.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
An entrepreneur panel at the Manova Summit in Minneapolis, Minnesota delved into the subject of how mental health digital therapeutics augment – instead of interrupt – the work of clinicians and care professionals.
Study participants are using VivaLNK's Vital Scout wearable patches as researchers examine whether there are associations between stress and depression in teenagers.
Digital health for chronic illness is no longer a technology problem – it’s an implementation problem.
A new study suggests owning a dog can significantly reduce the risk of a cardiovascular-related death. I challenge you to show me any drug or surgery that does the same without side effects and at a comparable cost.
The study identified 18 eligible randomized controlled trials of 22 smartphone apps, with outcome data from 3,414 participants.